is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
#LivingWithEczema has been established to give members of the community the knowledge to tackle their condition.
14 May 2019
“In order to execute this vision, we have set-up the #LivingWithEczema network which will bring together thought leaders, policy makers, healthcare professionals and media to raise awareness around Atopic Dermatitis in the UAE. I am currently leading the network, with the support of Sanofi, and we are in the process of inviting more members to join the team and will keep you posted on our course of action,” Dr. Al Hammadi tells Arab Health Magazine.
What is AD?
AD is a chronic, immune-mediated disease that is systemic and visible on the skin. In moderate-to-severe cases, its symptoms can include an intense, relentless itch, skin dryness, cracking, redness, crusting and oozing.
“AD affects 10 to 25 per cent of children, around 10 to 20 per cent of adults globally. These individuals are not only battling physical symptoms but are also dealing with its impact on their mental wellbeing and quality of life, which is an important aspect to address,” says Dr. Al Hammadi.
References available on request.